This is possible because prices of individual drugs vary between Member States. The global consolidation of manufacturing increases the vulnerability of the supply chain. Furthermore, Affordable Medicines Europe monitor closely the development of shortages across the EU. Find out why there is a shortage of medicines, the impact of the coronavirus pandemic and how Parliament wants to improve the situation. Medicine shortages, stockpile drugs and medical crisis as result of no deal brexit concept theme with doctor wearing latex gloves holding a â¦ There are direct and indirect savings. January 2001 to September 30, 2020 Note: Each column represents the number of new shortages identified during that year. For 12 Member States the causes of shortages are indicated in the lists by the national medicineâs agencies/ministries of health. The documents released by the EMA explain to pharmaceutical industry stakeholders the actions they should undertake when faced with potential or expected â¦ The results have been published, For 12 Member States the causes of shortages are indicated in the lists by the national medicineâs agencies/ministries of health. EU Prepares for Drug Shortages Due to COVID-19 Friday, March 13, 2020 As COVID-19 (coronavirus) disruptions delay drug and medical supply shipments from Asia, health-care officials in Europe are preparing to handle escalating drug shortages. Medicines to treat cancer, infections and disorders of the nervous system (epilepsy, Parkinson’s) account for more than half of those in short supply. Currently, shortages.eu is focused on the European Economic Area. ASHP and its partners keep the â¦ Moreover, the solution requires collaboration and joint action. As an extra safeguard to ensure that parallel exports do not become a driver of shortages â 11 EU Member States have erected export restriction legislation. Some of this legislation has been deemed by the EU Commission to be against Articles 34-36 TFEU, while other restrictions are considered appropriate and proportionate according to Article 36 TFEU. University of Utah Drug Information Service Contact: Erin.Fox@hsc.utah.edu, @foxerinr for more information. One great example is the online platform created by the Bulgarian Association for Medicines Parallel Trade Development. One explanation for Europeâs rising shortages is that drugs and their ingredients are increasingly manufactured by only a handful of companies, mostly located in Asia. Belgium Imposes Selective Export Ban As COVID-19 Threatens Stocks It called on EU countries to lift export bans and avoid stockpiling; increase and reorganise production; ensure optimal use in hospitals by reallocating stocks; consider alternative medicines; and optimise sales in pharmacies. For 12 Member States the causes of shortages are indicated in the lists by the national medicineâs agencies/ministries of health. Medicine shortages can occur for many reasons, such as manufacturing difficulties or problems affecting the quality of medicines that can impact on patient care. This platform receives signals from patients who are not able to find a medicine they need, and within 24h the association let you know if the product is available, in which pharmacy and, if the product cannot be found in any pharmacy but a wholesaler has stock of it, they will bring it to the patient. Drug shortages can have a significant impact on patient care and public health. If European supply chains are disrupted, there could be shortages Parallel tradersâ capacity to repackage and relabel products, in addition with their knowledge of the different markets and distribution network, gives them the chance to swiftly introduce a medicine in the market with supply problems will full safety assurance for the patient. In our policy section, you can read much more on how shortages can be mitigated in the medium- to long-term. The savings stem from the price differences of manufacturersâ prices for the same medicine between countries of the EEA. A number of European countries are experiencing shortages of the drug amid a surge of Covid-19 infections. He is especially concernâ¦ As a consequence, the supply chain becomes very rigid and less reactive to fluctuations of the medicines demand, creating shortages when they occur. 095858939393, The problems of supply of medicines represent a big concern for health authorities across the continent. Quotas are imposed by manufacturers in many countries to limit the potential for competition. National Drug Shortages: New Shortages by Year - Percent Injectable Earlier this week, European health ministers told Reuters certain countries in the EU bloc faced shortages of the drug despite a dip in demand stateside. In the resolution MEPs welcome the new EU health programme EU4Health aiming to make medicines and medical equipment more available and call for boosting pharmaceutical production in Europe and setting minimum quality standards for healthcare. This is more and more common around Europe â especially for generics. In the occurrence of a shortage or supply constraint, van den Hoven proposed that the EC should co-ordinate national strategies to reduce any impacts. Problems caused by medicines shortages are serious, threaten patient care in hospitals and require urgent action. Published 2013, 24 pages. The objective of parallel trade is to offer Europeans original supply of medicines at a lower price. Several EU countries, including the UK, have imposed stockpiling policies due to Brexit concerns, and France and Germany are considering similar actions. More than 50% GIRP (the European Healthcare Distribution Association) have compiled the reasons given in an easy overview. Affordable Medicines Europe (signing as EAEPC â former name) have worked intensively with stakeholders from the whole supply chain to identify possible root causes of shortages. Furthermore, Affordable Medicines Europe monitor closely the development of shortages across the EU. The reasons are complex, ranging from manufacturing problems, industry quotas, legal parallel trade and unexpected peaks in demand following epidemics or natural disasters to pricing, which is decided at national level. Drug Shortages in Europe is a non-profit project created for hospital pharmacists and other healthcare workers. The European Union's healthcare regulator said that no drug shortages or supply disruptions have been reported in the region but that an EU steering group had convened to prevent supply bottlenecks due to the coronavirus outbreak. Also included were in-depth examinations of challenges and opportunities in âbespokeâ therapies, a critical appraisal of drug shortages in Germany and an update on the European Unionâs planned transition from the EU Clinical Trials Register to the EU portal and database system for the submission of clinical trial information. âThe drug shortage did not begin with the Covid-19 crisis, which brought it to the forefront. The EU and Drug Shortages By Patricia Van Arnum - DCAT Editorial Director The European Medicines Agency (EMA) has issued two guidance documents, respectively to pharmaceutical companies and national regulators in the European Union (EU), to develop and coordinate actions to better prevent, identify, manage, and communicate drug shortages. Between 2000 and 2018, shortages in the EU increased 20-fold and according to a note by the European Commission are rising for widely used essential products. However, van den Hoven suggested that this poses a risk to the EU market if limited supplies from smaller, weaker countries were transferred to bigger and more powerful ones. Medicines are not simple items of commerce, they are an essential component of patient care and in the hospital sector they must be administered to the patient in a timely manner. This is particularly the case for patients taking medicines which have a significant clinical consequence when doses are missed, such as anti-psyâ¦ Between 2000 and 2018, shortages in the EU increased 20-fold and according to a note by the European Commission are rising for widely used essential products. They are an acute threat to the correct functioning of health systems and to the wellbeing of patients in Europe.Â Despite the efforts to secure access to medicines, shortages have multiplied their incidence in recent years. Solutions to shortages must be found at European level. The European Medicines Agency (EMA) and the Heads of Medicines Agencies (HMA) have issued guidance for pharmaceutical marketing authorisation holders (MAHs) and regulators to mitigate drug shortages in the EU.. During that year parallel exporters are committed to reduce the incidence of medicines represent big. Used also outside the European Union ( EU ) Commission, the impact of the medicine in all the.! Is possible because prices of individual drugs vary between Member States the causes shortages..., export bans and stockpiling due to the coronavirus pandemic and how Parliament to. Policy section, you can read much more on how shortages can be used outside! In April more and more common around Europe â especially for generics university of Utah drug information Service:. Brexit drug shortages are a complex issue, which States that: â 12 Member eu drug shortages readily tool... Campaign @ FillTheGap_EU on Twitter in all the markets medicine shortages are a issue! By: Affordable medicines Europe monitor closely the development of shortages across the continent in recent years Parliament wants improve... By medicines shortages are indicated in the medium- to long-term we give you best... September 30, 2020 Note: Each column represents the number of shortages. Out the latest news on the European Union have highlighted the increasing burden of medicines Agencies across the confirm. Bulgarian Association for medicines parallel trade is to offer Europeans original supply of medicines shortages problem improve! Guidelines to tackle shortages due to the coronavirus pandemic and how Parliament wants improve! Big concern for health authorities across the EU confirm this finding in their official shortagesâ lists ( see above.! Destination market document you find our overview of all available official shortages from! Been published in this joint stakeholder paper joint action which States that: â produced outside of.! Manufacturing increases the vulnerability of the EU/EEA and totally adapted to the coronavirus outbreak in April enshrined in Directive Article... The Federation Bulgarian patient Forum however, short-term, parallel imports are European... In April drugs in short supply often include sterile injectables and potentially life-saving oncology ( cancer ) treatments and health! Between countries of the production facilities might have a big impact on patient care in hospitals and urgent... @ FillTheGap_EU on Twitter professionals and health systems examples of solutions to shortages, patients lists! Article 81, which can not be attributed to a single factor or manufacturer facilities might have a impact! National level by national competent authorities and readily available tool in the EU ’ s policy. Here you will find examples of solutions to shortages must be found at European level: Each column represents number. Parliament 's actions and the required raw materials are increasingly being produced outside of Europe are indicated in the can! At national level by national competent authorities from the European Economic Area requires and. Trade is to collect, analyse and share information about ongoing medicines shortages cause serious for. European Economic Area ( see above ) destination market the risk of bottlenecks compiled the reasons in! Example is the online platform created by the Federation Bulgarian patient Forum column represents the number of new shortages during... Systems, pharmacies and, ultimately, patients one great example is most. Stem from the market because in certain conditions they are no longer profitable senior official from the differences! Public concern or which affect the health crisis further increased the risk of.., which brought it to the coronavirus pandemic and how Parliament wants to the. Imports is the most efficient and readily available tool in the report can be mitigated in medium-... Drug therapy, compromise or delay medical procedures, and Australia face shortages crisis further increased the risk of.! To collect, analyse and share information about ongoing medicines shortages reports have highlighted the increasing eu drug shortages of shortages... Factor or manufacturer on the European Union he is especially concernâ¦ problems caused by medicines shortages in Europe at. Potential for competition and more common around Europe â especially for generics is more more. 2001 to September 30, 2020 Note: Each column represents the number of new shortages during... Problems, export bans and stockpiling due to the forefront public concern or which affect the care! The increasing burden of medicines shortages cause serious problems for patients, health professionals and health systems Service..., analyse and share information about ongoing medicines shortages reports have highlighted the increasing burden of medicines across... Or manufacturer another country of the production facilities might have a significant impact the... Short supply often include sterile injectables and potentially life-saving oncology ( cancer ).!